Want to join the conversation?
$CVS 2Q15 Q&A: Heinbockel of Guggenheim asked on ongoing consolidation in PBM space. Larry replied that the timing of selling season, particularly the 16 season was really unaffected by some of the M&A activities that occurred. Those opportunities are in front of us and CVS has already begun on 17 for some of the health plan clients out there.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.